We are happy to share a milestone in our journey towards fully automated pre-procedural TAVR planning.
4TAVR**, our cloud-based, AI-driven platform, delivered fully automated anatomical measurements with high accuracy and 100% reproducibility.
Results of the AI-TAVI validation study were presented at CRT2024 by Moritz C. Wyler von Ballmoos with simultaneous publication in Cardiovascular Revascularization Medicine (CRM, first author Stefan Toggweiler). Stay tuned for more updates!
Click on the link to get to the paper: https://www.sciencedirect.com/science/article/pii/S1553838924000927?via%3Dihub
** 4TAVR has not yet been FDA-cleared or CE-Marked.